Theory Paper IDrNB Cardiology – Theory Notes
THE FONTAN HEART (SINGLE VENTRICLE PALLIATION)
IPART 1 — THE FONTAN HEART: DEFINITION & ANATOMICAL CONFIGURATION
- Definition (ESC 2020 ACHD Guidelines): The Fontan operation is the final definitive palliation for congenital single-ventricle physiology (e.g., Tricuspid Atresia, Hypoplastic Left Heart Syndrome). It completely bypasses the right heart by directly connecting systemic venous return to the pulmonary arteries.
- Modern Configurations (Total Cavopulmonary Connection - TCPC):
- Lateral Tunnel: The SVC is anastomosed to the RPA (Glenn shunt), and an intra-atrial baffle directs IVC blood to the pulmonary arteries.
- Extracardiac Conduit (Current Gold Standard): A Gore-Tex tube connects the IVC directly to the pulmonary artery, entirely bypassing the right atrium. Advantage: Drastically lowers the incidence of atrial arrhythmias and saves atrial kinetic energy.
IITHE “FONTAN PARADOX” (UNIQUE HEMODYNAMICS)
- The Paradox: There is no sub-pulmonary ventricular pump. Pulmonary blood flow is completely passive, driven exclusively by a chronically elevated Central Venous Pressure (CVP, usually 12-15 mmHg) and actively hindered by Pulmonary Vascular Resistance (PVR).
- The Result: The patient lives in a state of chronic systemic venous congestion (high CVP) and chronic diminished cardiac output (decreased ventricular preload).
IIISEQUELAE OF THE FAILING FONTAN
- Natural History: The Fontan circuit is a palliative time-bomb; it inherently fails over decades.
- Fontan-Associated Liver Disease (FALD): Universal in adult patients. Chronic hepatic congestion leads to cardiac cirrhosis and Hepatocellular Carcinoma (HCC). Routine hepatic surveillance (ultrasound/elastography and AFP) is recommended.
- Protein-Losing Enteropathy (PLE): Severe intestinal lymphatic congestion causes massive enteric protein loss (low albumin, severe edema). Highly lethal.
- Plastic Bronchitis: Lymphatic failure causing dense, cast-like secretions in the bronchial tree, leading to asphyxiation.
- Arrhythmias: Intra-atrial Re-entrant Tachycardia (IART) is the most common cause of sudden decompensation. Catheter ablation in an experienced ACHD centre is preferred.
IVPART 2 — MANAGEMENT OF A CYANOTIC (“TET”) SPELL: DEFINITION & PATHOPHYSIOLOGY
- Definition: A life-threatening hypercyanotic paroxysm classic to Tetralogy of Fallot (TOF), peaking between 2 to 4 months of age.
- The Mechanism: Triggered by crying, feeding, or defecation. A sudden surge in catecholamines causes violent spasm of the Right Ventricular Outflow Tract (RVOT) infundibulum. This drops pulmonary blood flow to near zero and forces a massive right-to-left shunt of deoxygenated blood across the VSD into the aorta.
- The Clinical Trap: The classic TOF murmur disappears during a spell because flow across the stenotic RVOT has completely ceased.
VACUTE PHARMACOLOGICAL & MECHANICAL MANAGEMENT (THE ALGORITHM)
- Goal: Strictly hemodynamic: increase Systemic Vascular Resistance (SVR) and decrease RVOT spasm.
AMechanical Maneuvers (First-Line)
- Knee-Chest Position (Infants) / Squatting (Older Children): Kinking the femoral arteries massively and instantly increases SVR, forcing blood back across the VSD and into the pulmonary bed.
BPharmacological Rescue
- 100% Oxygen: Acts as a potent pulmonary vasodilator to reduce PVR.
- Morphine Sulfate (0.1 mg/kg IV/SC): The ultimate sedative. It depresses the hyperpneic respiratory drive, breaks the panic cycle, and blunts the catecholamine surge driving the RVOT spasm.
- Intravenous Fluid Bolus (Isotonic Saline): Rapidly increases RV preload to physically pry open and force blood across the spasming RVOT.
- Beta-Blockers (IV Esmolol or Propranolol): The specific antidote to the infundibular spasm. Reverses the catecholamine-driven hypercontractility.
- Vasopressors (IV Phenylephrine): A pure alpha-1 agonist. It massively spikes SVR without any beta-1 chronotropic effects (which would worsen the spasm). Reduces the right-to-left shunt.
- Sodium Bicarbonate: Administered to correct severe metabolic acidosis, because acidosis directly increases PVR and worsens the right-to-left shunt.
VILANDMARK ADVANCES (ESC 2020 ACHD / AHA 2019)
- The Fontan Anticoagulation Debate:
- Current Guideline (ESC 2020): Routine prophylactic anticoagulation in a well-functioning Fontan is not universally recommended (antiplatelet or anticoagulant therapy is individualized). However, if there is any history of atrial arrhythmia, thrombus, or a prior stroke, lifelong systemic anticoagulation (Warfarin preferred over DOACs due to lack of robust DOAC data) is a strict Class I, LOE B mandate.
- Pulmonary Vasodilators in the Fontan:
- The Advance: Off-label use of Endothelin Receptor Antagonists (Bosentan) or PDE-5 inhibitors (Sildenafil) is increasingly used to actively lower PVR and effectively “suck” blood through the passive Fontan circuit, significantly improving exercise capacity.
- Emergency TOF Palliation:
- If a Tet Spell is completely refractory to medical therapy, emergency surgical palliation (modified Blalock-Taussig-Thomas shunt) or urgent transcatheter RVOT stenting is mandated as a life-saving bridge to total repair.
VIIEXAM TIPS & LEXICON
- Catchwords to underline in your exam:
- “Extracardiac conduit (Total Cavopulmonary Connection)”
- “Fontan Paradox (High CVP, Low Cardiac Output)”
- “Protein-Losing Enteropathy (PLE) & FALD”
- “Infundibular spasm (Tet Spell)”
- “Knee-chest position (Increases SVR)”
- “IV Phenylephrine (Pure Alpha-1 agonist to reverse shunt)”
VIIIEXECUTION TIP
- Draw the “Hemodynamic Seesaw of a Tet Spell” on your exam sheet: Draw a fulcrum (seesaw).
- Left Side (Down): Write SVR. (Trigger: Crying/Vasodilation).
- Right Side (Up): Write PVR / RVOT Spasm.
- Arrow: Draw a massive arrow pointing from the Right Ventricle to the Aorta (Right-to-Left Shunt).
- Therapy Box: Draw an arrow pushing SVR UP (Knee-chest, Phenylephrine) and an arrow pushing RVOT Spasm DOWN (Beta-blockers, Morphine). This visual proves to the examiner that you are not just memorizing drugs, but actively manipulating the physics of congenital shunts.
meritmedscript.comDr. Sidhartha Mullapudi
